The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults

Autor: Elske Sieswerda, Hannelore I. Bax, Jacobien J. Hoogerwerf, Mark G. J. de Boer, Marja Boermeester, Marc J. M. Bonten, Douwe Dekker, Roy Gerth van Wijk, Nicole P. Juffermans, Marnix Kuindersma, Paul D. van der Linden, Damian C. Melles, Peter Pickkers, Jeroen A. Schouten, Jasper R. Rebel, Arthur R. H. van Zanten, Jan M. Prins, W. Joost Wiersinga

Publikováno v: BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-16 (2022)

Abstract Background The Dutch Working Party on Antibiotic Policy (SWAB) in collaboration with relevant professional societies, has updated their evidence-based guidelines on empiric antibacterial therapy of sepsis in adults. Methods Our multidiscipli

Externí odkaz: https://doaj.org/article/428bc82ef7f045c2b74f25abb5e6bb8a

Using a BonE BiOPsy (BeBoP) to determine the causative agent in persons with diabetes and foot osteomyelitis: study protocol for a multicentre, randomised controlled trial

Autor: Meryl Cinzía Tila Tamara Gramberg, Rimke Sabine Lagrand, Louise Willy Elizabeth Sabelis, Martin den Heijer, Vincent de Groot, Max Nieuwdorp, Willemijn Kortmann, Elske Sieswerda, Edgar Josephus Gerardus Peters

Publikováno v: Trials, Vol 22, Iss 1, Pp 1-10 (2021)

Abstract Background Diabetic foot osteomyelitis (DFO) poses a major disease burden. It can generally be treated with long-term antibacterial therapy. International guidelines recommend to base antibacterial therapy choices on percutaneous bone biopsy

Externí odkaz: https://doaj.org/article/43dea9d9ad954665a31d47bc0f7cf3a5

Vitek® 2 MICs as first-line phenotypic screening method for carbapenemase-producing Pseudomonas aeruginosa

Autor: Thijs Bosch, Jacqueline M Lankelma, Karin van Dijk, Elske Sieswerda, Leo M. Schouls

Publikováno v: Future Microbiology. 16:777-781

Aim: To define sensitivity and specificity of Vitek® 2 MICs as phenotypic screening method for carbapenemase-producing Pseudomonas aeruginosa. Materials & methods: We determined Vitek® 2 MICs of antipseudomonal antimicrobials in 130 unrelated carba

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::df90a443b1b89612945c83a7e7c52239
https://doi.org/10.2217/fmb-2020-0024

Duration of antibiotic treatment for foot osteomyelitis in people with diabetes

Autor: Meryl Cinzía Tila Tamara Gramberg, Elske Sieswerda, Suzanne AV van Asten, Louise WE Sabelis, Ralph de Vries, Edgar JG Peters

Publikováno v: Cochrane Database Syst Rev
Gramberg, M C T T, Sieswerda, E, van Asten, S A V, Sabelis, L W E, de Vries, R & Peters, E J G 2022, ' Duration of antibiotic treatment for foot osteomyelitis in people with diabetes ', Cochrane Database of Systematic Reviews, vol. 2022, no. 4, CD014750 . https://doi.org/10.1002/14651858.CD014750

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To compare the effects of a shorter antibacterial treatment duration with a longer antibacterial treatment duration in people with diabetes and foot

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e078a6d3d1dcadf7bb882b9df2f8a54d
https://doi.org/10.1002/14651858.cd014750

Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study

Autor: Jan M. Prins, Rogier P. Schade, Jara R. de la Court, David T P Buis, Reinier M. van Hest, Suzan F M Nijman, Lilian J. Meijboom, Elske Sieswerda, Caroline E. Visser, Marianne Kuijvenhoven, Sophie Coenen, Kim C.E. Sigaloff

Publikováno v: Antimicrobial Resistance and Infection Control, 10(1):155. BioMed Central
Antimicrobial Resistance and Infection Control, Vol 10, Iss 1, Pp 1-10 (2021)
Antimicrobial Resistance and Infection Control
Coenen, S, de la Court, J R, Buis, D T P, Meijboom, L J, Schade, R P, Visser, C E, van Hest, R, Kuijvenhoven, M, Prins, J M, Nijman, S F M, Sieswerda, E & Sigaloff, K C E 2021, ' Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria : a retrospective cohort study ', Antimicrobial Resistance and Infection Control, vol. 10, no. 1, 155, pp. 155 . https://doi.org/10.1186/s13756-021-01024-4, https://doi.org/10.1186/s13756-021-01024-4
Antimicrobial resistance and infection control, 10(1):155. BioMed Central

Background We defined the frequency of respiratory community-acquired bacterial co-infection in patients with COVID-19, i.e. patients with a positive SARS-CoV-2 PCR or a COVID-19 Reporting and Data System (CO-RADS) score ≥ 4, based on a complete cl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76e60d78a5ac8d60a6212b41ce1d6b03
https://research.vumc.nl/en/publications/4faa3fce-61b1-4b48-881d-d6c72ee4de65